<DOC>
	<DOCNO>NCT01906801</DOCNO>
	<brief_summary>The purpose study compare pain score , WOMAC total subscores , actual change joint space width rate gastrointestinal side effect 4 , 8 , 12 , 24 week dual-therapy diacerein glucosamine versus mono-therapy glucosamine OA patient</brief_summary>
	<brief_title>Clinical Efficacy Glucosamine Plus Diacerein Versus Mono-therapy Glucosamine</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Diacetylrhein</mesh_term>
	<criteria>Adult patient age 50 year old diagnose primary secondary osteoarthritis knee base clinical criterion American College Rheumatology Clinical diagnosis primary osteoarthritis Mild deformity Clinical ( varus valgus deformity , crepitus ) ? Physical examination grade 0 assessed stress test Radiographic assessment ( Kellgranelawrance type IIIII ) , minimum baseline medial tibiofemoral JSW _2 mm . Willing participate provide write informed consent Nonsecondary osteoarthritis Rheumatoid arthritis , inflammatory arthritis ( e.g . SLE , Gout ) , post traumatic osteoarthritis , receive intraarticular treatment signal joint product ( corticosteroid previous 2 month , glycosaminoglycans/hyaluronic acid previous 6 month ) undergo joint lavage andarthroscopic procedures previous 6 month . No contraindication use diacerein glucosamine Noncurrent exusers oral SYSADOA ( e.g. , glucosamine sulphate , chondroitin sulphate , diacerein , piascledine ) , antidepressant , tranquilliser , antacid antibiotic know hypersensitivity diacerein , similar compound , excipients paracetamol</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>Osteoarthritis</keyword>
	<keyword>Glucosamine sulfate</keyword>
	<keyword>Diacerein</keyword>
	<keyword>Randomized control trial</keyword>
</DOC>